US health regulator advisers have voted against a therapy based on MDMA for PTSD patients.
Archived version: https://archive.ph/SNfgz
US health regulator advisers have voted against a therapy based on MDMA for PTSD patients.
Archived version: https://archive.ph/SNfgz
We have to remember that post-hydrocodone, the FDA is wary about randomly approving drugs that “might help” but have the tendency to be habit forming.
There’s a good reason for this vote.